Recerca

Malalties infeccioses i microbioma

Buscador de publicacions

Publicacions

  • Hernández-García M, Roldan-Berengue E, Guitart-Pardellans C, Girona M, Argüello G, Pino R, Fernández de Sevilla-Estrach M, García-García JJ and Jordán-García I.

    Multisystem inflammatory syndrome in children (MIS-C) and sepsis differentiation by a clinical and analytical score: MISSEP score

    EUROPEAN JOURNAL OF PEDIATRICS . 182(11): 5109-5118. Nº de cites: 2

    [doi:10.1007/s00431-023-05168-w]

  • de Salazar A, Martínez MJ, Navero-Castillejos J, Negredo A, Galán JC, Rojo Molinero E, Lagarejos E, Munoz-Almagro C, Hernández Rodríguez Á, Lepe JA, Antón Pagarolas A, Pérez Castro S, Zamora Cintas MI, Domínguez-Gil González M, Niubó-Bosch J, Gutiérrez Arroyo A, Vazquez A, García F and Sánchez-Seco Fariñas MP.

    The imperative for quality control programs in Monkeypox virus DNA testing by PCR: CIBERINFEC quality control

    JOURNAL OF MEDICAL VIROLOGY . 95(11): 29240-29240.

    [doi:10.1002/jmv.29240]

  • Blanco Y, Escudero D, Lleixà C, Llufriu S, Egri N, García RR, Alba M, Aguilar E, Artola M, Aldea Novo M, Alvarez S, Caballero E, Cabrera-Maqueda JM, Fonseca E, Guasp M, Hernando A, Martinez-Hernandez E, Olivé-Cirera G, Lopez-Contreras J, Martín-Aguilar L, Martinez-Martinez L, Rombauts A, Rodés M, Sabater L, Sepulveda M, Solana E, Tejada-Illa C, Vidal-Fernández N, Vilella A, Fortuny-Guasch C, Armangue-Salvador T, Dalmau JO, Querol L and Saiz A.

    mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 10(6): . Nº de cites: 3

    [doi:10.1212/NXI.0000000000200163]

  • Soler-García a, Gamell Fullà A, Manuel Monsonis Cabedo, Korta-Murua JJ, Espiau M, Rincón-López E, Rodríguez-Molino P, Pérez-Porcuna T, Bustillo-Alonso M, Santiago B, Tebruegge M and Noguera-Julián A.

    The Value of the Second QuantiFERON-TB Gold-Plus Antigen Tube at Diagnosis and at Treatment Completion in Spanish Children With Tuberculosis.

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 42(11): 1017-1020. Nº de cites: 1

    [doi:10.1097/INF.0000000000004058]

  • Francisco L, Cruz-Cañete M, Pérez C, Couceiro JA, Otheo E, Launes-Montana C, Rodrigo C, Jiménez AB, Llorente M, Montesdeoca A, Rumbao J, Calvo C, Frago S and Tagarro A.

    Nirsevimab para la prevención de la enfermedad por virus respiratorio sincitial en niños. Posicionamiento de la Sociedad Española de Infectología Pediátrica

    ANALES DE PEDIATRIA . 99(4): 257-263.

    [doi:10.1016/j.anpedi.2023.09.006]

  • Armangue-Salvador T, Olivé-Cirera G, Martínez-Hernandez E, Rodes M, Peris-Sempere V, Guasp M, Ruiz R, Palou E, González A, Marcos MÁ, Erro ME, Bataller L, Corral-Corral Í, Planagumà J, Caballero E, Vlagea A, Chen J, Bastard P, Materna M, Marchal A, Abel L, Cobat A, Alsina L, Fortuny-Guasch C, Saiz A, Mignot E, Vanderver A, Casanova JL, Zhang SY and Dalmau J.

    Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies.

    BRAIN . 146(10): 4306-4319. Nº de cites: 23

    [doi:10.1093/brain/awad238]

  • Francisco, Laura, Cruz-Canete, Marta, Perez, Carlos, Couceiro, Jose Antonio, Otheo, Enrique, Launes-Montana C, Rodrigo, Carlos, Jimenez, Ana Belen, Llorente, Marta, Montesdeoca, Abian, Rumbao, Jose, Calvo, Cristina, Frago, Susana and Tagarro, Alfredo.

    Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP).

    ANALES DE PEDIATRIA . 99(4): 257-263. Nº de cites: 11

    [doi:10.1016/j.anpede.2023.09.006]

  • Izquierdo C, Ciruela P, Soldevila N, García-García JJ, Gonzalez-Peris S, Díaz-Conradi A, Viñado B, Fernández de Sevilla-Estrach M, Moraga-Llop F, Munoz-Almagro C, Domínguez A and Barcino Working Group.

    Changes in Invasive Pneumococcal Disease in the Paediatric Population in the Second COVID-19 Pandemic Year

    Vaccines . 11(10): .

    [doi:10.3390/vaccines11101548]

  • Hernández-García M, Claudia Solito, Pavón Ortiz A, Arguedas Casamayor N, Melé-Casas M, Pons-Tomàs G, Fernández de Sevilla-Estrach M, Pino R, Launes-Montana C, Guitart-Pardellans C, Girona M, Jordán-García I and García-García JJ.

    Characteristics and Risk Factors Associated with SARS-CoV-2 Pneumonias in Hospitalized Pediatric Patients: A Pilot Study

    CHILDREN-BASEL . 10(10): . Nº de cites: 1

    [doi:10.3390/children10101703]

  • Turkova A, White E, Kekitiinwa AR, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe GM, Moloantoa T, Srirompotong U, Mosia NR, Puthanakit T, Kobbe R, Fortuny-Guasch C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi MF, Klein N, Mujuru HA, Kityo C, Cotton MF, Ferrand RA, Giaquinto C, Rojo P, Violari A, Gibb DM and Ford D.

    Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.

    LANCET CHILD & ADOLESCENT HEALTH . 7(10): 718-727.

    [doi:10.1016/S2352-4642(23)00164-5]